Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years – VISION and IVY Networks, September 2023-January 2024
Related Posts
Haidar A, Rikhi R, Watson KE, Wood AC, Shapiro MD. Association Between Ultraprocessed Food Consumption and Cardiovascular Disease Risk: MESA (Multiethnic Study of Atherosclerosis). JACC[...]
Kasonga JN, Hoff NA, Merritt S, Fandema E, Nkamba DM, Zanga-Goumet HE, Bobo E, Tangney S, Mafuta E, Bangelesa F, Babakazo P, Kokolomami J, Stahley[...]
Bergman J, Giboney P, Waterman B, Yee H. eConsult-Integrated Care to Improve Specialty Access. JAMA Intern Med. 2026 Mar 16. doi: 10.1001/jamainternmed.2025.8352. Epub ahead of[...]